AR006754A1 - Derivados de quinoxalina utiles en terapia - Google Patents

Derivados de quinoxalina utiles en terapia

Info

Publication number
AR006754A1
AR006754A1 ARP970100842A ARP970100842A AR006754A1 AR 006754 A1 AR006754 A1 AR 006754A1 AR P970100842 A ARP970100842 A AR P970100842A AR P970100842 A ARP970100842 A AR P970100842A AR 006754 A1 AR006754 A1 AR 006754A1
Authority
AR
Argentina
Prior art keywords
alkyl
heterocyclyl
aryl
optionally substituted
therapy
Prior art date
Application number
ARP970100842A
Other languages
English (en)
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of AR006754A1 publication Critical patent/AR006754A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Provee compuestos de la fórmula (I), en donde R1 y R2 son independientemente Cl o alquilo de C1-6: R3 es XCO2R4, XCONHSO2R5, YNHSO2R5o XR6: R4 es H o alquilo de C1-6(opcionalmente substituido por arilo o heterocililo; R5 esCF3, heterociclilo o alquilo de C1-6, (opcionalmentesustituido por arilo o heterociclilo), R6 es un heterociclo ácido; X es un diradical alquilo de C1-6 (opcionalmente substituido por arilo oheterociclilo); y Y es un radical alquilo de C2-6 (opcionalmente substituido por arilo o heterociclilo); siempre que cuando R1 y R2 son cada uno Cl,entonces R3 no es CH2CO2H, CH2CO2CH3, CH2CH2NHSO2CF3 o 5-tetrazolilmetilo; y sales farmacéuticamente aceptables de los mismos; esos compuestos estánindicados como angiolíticos, anticonvulsivos, analgésicos y neuroprotectores.
ARP970100842A 1996-03-01 1997-03-03 Derivados de quinoxalina utiles en terapia AR006754A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9604400.3A GB9604400D0 (en) 1996-03-01 1996-03-01 Compounds useful in therapy

Publications (1)

Publication Number Publication Date
AR006754A1 true AR006754A1 (es) 1999-09-29

Family

ID=10789694

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970100842A AR006754A1 (es) 1996-03-01 1997-03-03 Derivados de quinoxalina utiles en terapia

Country Status (13)

Country Link
US (1) US5863917A (es)
EP (1) EP0792874A1 (es)
JP (1) JPH101474A (es)
AP (1) AP9700933A0 (es)
AR (1) AR006754A1 (es)
AU (1) AU1877497A (es)
CA (1) CA2198687A1 (es)
GB (1) GB9604400D0 (es)
ID (1) ID19871A (es)
MA (1) MA26421A1 (es)
MX (1) MXPA97001590A (es)
TN (1) TNSN97042A1 (es)
WO (1) WO1997031902A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721256A (en) * 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds
EP1211239A4 (en) * 1999-09-06 2003-08-06 Takeda Chemical Industries Ltd METHOD FOR PRODUCING 2,3-DIHYDROAZEPINE DERIVATIVES
TW200403066A (en) * 2002-04-30 2004-03-01 Novartis Ag New uses of substituted aminoalkanephosphonic acids
JP5351930B2 (ja) * 2004-02-04 2013-11-27 株式会社ファンケル 抗不安剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03220124A (ja) 1990-01-24 1991-09-27 Sumitomo Pharmaceut Co Ltd グルタミン酸拮抗剤
DK69790D0 (da) 1990-03-16 1990-03-16 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling af anvendelse
ATE128136T1 (de) 1990-05-31 1995-10-15 Merck Sharp & Dohme Dioxo-tetrahydrochinolinderivate.
GB9022785D0 (en) 1990-10-19 1990-12-05 Merck Sharp & Dohme Therapeutic agents
JPH05117276A (ja) * 1991-10-23 1993-05-14 Sumitomo Pharmaceut Co Ltd 新規な３環性キノキサリンジオン誘導体
US5187168A (en) * 1991-10-24 1993-02-16 American Home Products Corporation Substituted quinazolines as angiotensin II antagonists
EP0647137B1 (en) 1992-06-22 2008-08-13 The Regents Of The University Of California Glycine receptor antagonists and the use thereof
US5631373A (en) * 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
US5597922A (en) * 1994-07-29 1997-01-28 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Glycine receptor antagonist pharmacophore
GB9419318D0 (en) 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
WO1997031902A1 (en) 1997-09-04
AP9700933A0 (en) 1997-04-30
JPH101474A (ja) 1998-01-06
AU1877497A (en) 1997-09-16
EP0792874A1 (en) 1997-09-03
MA26421A1 (fr) 2004-12-20
GB9604400D0 (en) 1996-05-01
US5863917A (en) 1999-01-26
ID19871A (id) 1998-08-13
TNSN97042A1 (fr) 2005-03-15
CA2198687A1 (en) 1997-09-01
MXPA97001590A (es) 2004-09-13

Similar Documents

Publication Publication Date Title
DE69618231D1 (de) TETRAHYDROIMIDAZOPYRIDOINDOLDIONE ALS cGMP SPEZIFISCHE PDE HEMMER
EA200000098A1 (ru) 4-АМИНОПИРРОЛ(3,2-d)ПИРИМИДИНЫ В КАЧЕСТВЕ АНТАГОНИСТОВ РЕЦЕПТОРА НЕЙРОПЕПТИДА Y
TR200201205T2 (tr) N-ikame edilmiş karbamoiloksialkil-azolyum türevleri.
ATE219077T1 (de) Endothelin antagoniste
MX9300988A (es) Agentes antineoplasticos de quinobenzoxazina, quinobenzotiazina y pirido-acridina y composicion farmaceutica que los contiene.
DE69716925D1 (de) Isoxazoline derivate und ihre verwendung als antimikroben
PT1159279E (pt) 4-oxo-4,7-di-hidrotieno¬2,3-b|piridino-5-carboxamidas como agentes antivirais
ATE221064T1 (de) Cyclische amidderivate als neurokinin a antagonisten
DE69507293D1 (de) Benzamid-derivate als vasopressin-antagonisten
BR9809047A (pt) Derivados de isoquinolina substituìda e o uso dos mesmos como anticonvulsivantes
DK0733051T3 (da) Bicykliske, heterocykliske forbindelser som neurokinin A-antagonister
ATE218888T1 (de) 1,3-bis-(n-lactamyl)propane und deren pharmazeutische und kosmetische verwendung
PT1027348E (pt) 2-(2'-hidroxifenil)-benzotriazois utilizados como agentes estabilizadores da luz ultravioleta
ES2129483T3 (es) Derivados de indol-7-carboxamida como analgesicos.
AR006754A1 (es) Derivados de quinoxalina utiles en terapia
NO921159D0 (no) Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorer
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase
ES2104174T3 (es) Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos.
AR027578A1 (es) Derivados de indano
NO973441D0 (no) Substituerte fenylforbindelser som endotelinantagonister
DE69813886D1 (de) Naphthalin derivate
ATE277591T1 (de) Verwendung von n,n'- dibenzylethylendiamindiessigsäurederivaten zum schutz gegen verschmutzung
AR021094A1 (es) Compuestos heterociclicos inhibidores de la fosfodiesterasa iv y su uso para el tratamiento de enfermedades inflamatorias
ECSP972044A (es) Derivados de quinoxalina utiles en terapia
PT953563E (pt) Processo para a preparacao de derivados de depsipeptidos e novos compostos intermediarios para essa preparacao